Immunopharmacology, positioned at the intersection of immunology and pharmacology, is dedicated to shaping the immune system for therapeutic advantages. This interdisciplinary realm intricately explores the interplay between drugs and the immune system, investigating how pharmaceutical agents can enhance immune responses. Ongoing advancements continuously yield innovative immunomodulatory drugs, targeting specific pathways to address a range of conditions, from autoimmune disorders to cancer. Within immunopharmacology, there is a meticulous examination of the delicate balance between fortifying immune responses against pathogens and mitigating the adverse effects of excessive inflammation. Recognizing the immunomodulatory impacts of existing drugs becomes crucial, paving the way for repurposing medications to tackle emerging therapeutic challenges. The evolving landscape of immunopharmacology is defined by a dedicated pursuit of personalized immunotherapies, considering individual genetic variations in drug responses. As researchers unravel the intricate tapestry of the immune system, the promise of more precisely targeted and effective pharmacological interventions continues to grow.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico